Sorry, you need to enable JavaScript to visit this website.
Dynamic changes in legislation, patent expiry of block buster drugs, and increasing healthcare costs call for significant changes in the global pharmaceutical industry. These changes are driving pharma companies to explore pharmerging markets for per...